Defining Clinical Trial Data Strategy

Outsourcing your biometrics separately from your clinical services brings increased data quality and access, shorter timelines, and reduced costs. Implementing an overall clinical trial data strategy and data standards will maximise these savings.

At Outsourcing for Clinical Trials Europe 2021, we presented the best practices for defining an effective and efficient clinical trial data strategy. This presentation is now available on demand for you to watch anytime.

From this presentation you will:

  • Understand the risks of not having a data strategy and the benefits of having one
  • Learn the best practices around data strategies and standards
  • Identify the key steps in defining a data strategy and its use in standards development for CRFs and databases, data reporting, and key biometrics documentation

Register to Watch Now – Defining a Clinical Trial Data Strategy: How to Effectively Manage Your Key Asset


    Information privacy policy

    Consent pursuant to art. 6 Regulation (EU) 2016/679
    Upon reading the Information Notice outlined above:

    a) The undersigned shall give specific consent to the processing of personal data for marketing purposes (namely direct sale, sending of advertising material, market research and commercial communication). This consent is provided for marketing carried out by using both traditional systems (such as paper mail, phone call with operator) and automated systems of call or communication without operator, email, telefax, short text messages, MMS, or other automated means of communication. The data subject’s right to oppose the processing of their personal data for the purpose of direct marketing through automated contact methods also covers the traditional ones, with the possibility of exercising this right also partially. The data subject may express their consent to receiving communications for the abovementioned purposes exclusively through traditional methods of contact. The data subject’s refusal to give consent will result in the company’s failure to process their data for marketing purposes.

    b) The undersigned shall give specific consent to the processing of their personal data for profiling activities.

    c) The undersigned shall give specific consent to the processing of their personal data for communicating data to third parties for marketing purposes.